Correlation Between Histogen and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Histogen and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and SAB Biotherapeutics, you can compare the effects of market volatilities on Histogen and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and SAB Biotherapeutics.
Diversification Opportunities for Histogen and SAB Biotherapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Histogen and SAB is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Histogen i.e., Histogen and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Histogen and SAB Biotherapeutics
Given the investment horizon of 90 days Histogen is expected to under-perform the SAB Biotherapeutics. In addition to that, Histogen is 2.4 times more volatile than SAB Biotherapeutics. It trades about -0.3 of its total potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.05 per unit of volatility. If you would invest 292.00 in SAB Biotherapeutics on August 28, 2024 and sell it today you would earn a total of 5.00 from holding SAB Biotherapeutics or generate 1.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Histogen vs. SAB Biotherapeutics
Performance |
| Timeline |
| Histogen |
| SAB Biotherapeutics |
Histogen and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Histogen and SAB Biotherapeutics
The main advantage of trading using opposite Histogen and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Histogen vs. Eliem Therapeutics | Histogen vs. Scpharmaceuticals | Histogen vs. Milestone Pharmaceuticals | Histogen vs. Seres Therapeutics |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |